Dr. Kennecke on Suggested Multidisciplinary Actions for GEP-NETs

Publication
Video
Supplements and Featured PublicationsTherapeutic Updates in Neuroendocrine Tumors
Volume 1
Issue 1

Hagen F. Kennecke, MD, MHA, FRCPC, discusses multidisciplinary interactions within Virginia Mason Medical Center for patients with gastroenteropancreatic neuroendocrine tumors.

Hagen F. Kennecke, MD, MHA, FRCPC, a medical oncologist at Virginia Mason Medical Center, discusses multidisciplinary interactions within Virginia Mason Medical Center for patients with gastroenteropancreatic neuroendocrine tumors.

At a weekly tumor board, Kennecke will present a patient’s history, provide their background, and sequentially review pathology. Pathology must be analyzed to ensure the tumor grade is assessed with Ki-67 differentiation. After, imaging is conducted and repeat imaging is ordered if multi-phase CT scans are not completed, says Kennecke.

Then, the Gallium-68 dotatate (Netspot) PET/CT scan is reviewed and a Krenning score is assigned to all patients, grading to tumors from 0 to 4, according to Kennecke. From this evaluation of the patient, the tumor board decides what the best strategy is before discussing with the patients, he concludes.

Related Videos
Marc J. Braunstein, MD, PhD
Rita Nanda, MD
Vikram Narayan, MD
Daniel Olson, MD
A panel of 4 experts on colorectal cancer
A panel of 4 experts on colorectal cancer
Vishal Patel, MD, FAAD, FACMS, associate professor, Dermatology, George Washington (GW) School of Medicine & Health Sciences
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Adam S. Faye, MD
Siddartha Yadav, MD, FACP